A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

ClinicalTrials.gov ID: NCT06630234

Public ClinicalTrials.gov record NCT06630234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)

Study identification

NCT ID: NCT06630234
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Deciphera Pharmaceuticals, LLC; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Gastrointestinal Stromal Tumor (GIST)

Interventions

DCC-3009 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 9, 2024
Primary completion: Apr 30, 2028
Completion: Apr 30, 2028
Last update posted: Feb 4, 2026

2024 – 2028

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
HonorHealth	Scottsdate	Arizona	85258	Recruiting
UC San Diego Moores Cancer Center	La Jolla	California	92093	Recruiting
University of Colorado Anschutz Medical Campus	Aurora	Colorado	80045	Recruiting
Mayo Clinic Florida	Jacksonville	Florida	32224	Recruiting
University of Miami - Sylvester Comprehensive Cancer Center	Miami	Florida	33136	Recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
START Midwest	Grand Rapids	Michigan	49546	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Vanderbilt University-Ingram Cancer Center	Nashville	Tennessee	37232	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06630234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 4, 2026 · Synced Apr 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06630234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →